COVID Products – Directly Sourced From Manufacturers
We are the leading Covid products supplier and export all products like PPE kit, face shield, Nitrile gloves, N95 masks, and all other essential covid products
Question: Do you imagine that these revision processes in the health care supply chain continue to be strained due to the high demand for Personal Protective Equipment (PPE) at home and abroad, in the months of the COVID-19 pandemic. While sourcing PPE remains a challenge for many health care supply chain professionals, coordination within the health care sector has improved significantly, resulting in strategic partnerships to improve access to essential supplies while adding clarity to the vendor-waiting process Is.
Mike Schiller, senior director of supply chain for the Association for Health Care Resources and Materials Management (AHRMM), discusses the past, present and future state of the health care supply chain during the COVID-19 pandemic.
Q: Political leaders often emphasize the need to end our dependence on foreign manufacturers for a wide variety of goods, but especially for PPE. Have you noticed a tendency for providers to reevaluate their supply chains from overseas to domestic suppliers? And if so, do you think it's really a realistic endeavor?
Mike: Yes, I've heard this from conversations with coworkers and peers. Hospitals are looking to diversify their vendor portfolio as a whole and are looking at a number of different ways to do so. One notable option that supply chain professionals are considering is moving to multi-source contracts as opposed to single-source contracts.
Based on my conversations with a few GPOs (Group Purchasing Organisations), this is an opportunity to reevaluate the contracting process. vaccine supplier Domestic manufacturing brings with it the potential for increased supply costs on the road, but there seems to be an appetite for it in the face of the current environment.
Q: Along those lines, are you seeing that there are more "bad actors" in the products that offer space that are either of low quality or not present at all?
Mike: Yes. In early March, there was a significant increase in emails from non-traditional, or gray, manufacturers and suppliers claiming access to quality PPE with each of these manufacturers and suppliers.
The reality is that there are poor quality products that are sold in the U.S. have entered the health supply chain. Providers were required to take action to provide access to PPE, and the FDA through issuing an Emergency Use Authorization (EUA) permitting temporary use of non-FDA-approved products. Unfortunately, there are some bad actors in this field who either never shipped their products or didn't send bad/poor quality products.
Q: Has AHRMM taken any steps to help supply chain professionals through these gray manufacturers and suppliers?
Mike: At AHRMM, we started out acting as the clearinghouse for a hospital supply chain professional. We worked with a third-party partner, Vendormate, who offered to collaborate to allow us access to their vendor-revision program. As we received email requests from these gray manufacturers and suppliers; medical product distributors We can provide an initial high-level review - called the FACIS Level 1M review. Vendors that we consider acceptable, based on the waiting report, will be listed on the AHRMM COVID-19 resource website. To date, we have screened over 800 of these vendors and there are over 300 that are approved and listed on our website.